Put the Safe Delivery App in the hands of midwives in PNG
Donate today and help save the lives of mums and babies in PNG.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
HIV is a major focus at Burnet, with work on laboratory-based research into a cure, and on public health programs focused on education and prevention in Australia and overseas.
According to the UNAIDS, almost 38 million people live with HIV.
In 2020, there were 1.5 million new HIV infections and around 680,000 deaths from AIDS-related illnesses.
The COVID-19 lockdowns and other restrictions disrupted HIV testing and in many countries, lead to steep drops in diagnoses and referrals to HIV treatment.
The human immunodeficiency virus (HIV) infects cells of the immune system, causing it to become weak and making it more susceptible to infections. HIV is generally spread through unprotected sexual intercourse or contaminated blood but can also be spread from mother to child during pregnancy. There is no cure for HIV.
Acquired immunodeficiency syndrome (AIDS) is the most advanced stage of HIV infection. It can take 10 - 15 years for a HIV-infected person to develop AIDS but antiretroviral (ARV) drugs have made a huge difference in slowing or halting the progression to AIDS.
Service coverage is gradually increasing. In 2018, 62 per cent of adults and 54 per cent of children living with HIV in low and middle income countries were receiving lifelong antiretroviral therapy (ART).
World AIDS Day, held annually on 1 December, is an opportunity for people worldwide to support people living with HIV, and to commemorate those who have died.
A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression
A GIFT (Genital Inflammation Test) for HIV Prevention
A novel gel for targeting vaginal inflammation to prevent HIV transmission
ACCESS: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmitted Infections
Ageing Well with HIV
Antimicrobial and immune modulatory effects of vaginal microbiota metabolites
APPRISE - Centre for Research Excellence
Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar (ACCESS Myanmar)
Broadly neutralising anti-HIV antibodies and Fc Receptor function
co-EC Study: Eliminating hepatitis C/HIV coinfection
Community-Based Rapid HIV Testing Services
CREIDU: Centre for Research Excellence into Injecting Drug Use
DARE C: ATAHC II Substudy
Decision science using Optima
Depo Provera and Beyond
Development of a novel prophylactic vaccine candidate for HIV-1
Development of hydrogel based intravaginal drug delivery device
EVE-M
Getting to the heart of cardiovascular disease in HIV
Healthy Mothers, Healthy Babies
HIV Prevention Cohort
Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility
Inequalities in sexual and reproductive health in Asia and the Pacific
Mucosal injury from sexual contact (MISC)
Needle and Syringe Program (NSP) Snapshot Study
Predicting quality and potency of monoclonal and natural antibodies
PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)
Project Geldom
PRONTO! Rapid HIV point-of-care testing in Victoria
Sex, Drugs, and Rock'n'Roll (Big Day Out Study)
Sexual and reproductive health in Asia and the Pacific
SHARP: Sexual Health And Risk Prevention Study
SRHIP: Sexual & Reproductive Health Integration Project
SuperMIX: The Melbourne Injecting Drug User Cohort Study
Sustainability of HIV Services for Key Populations in Asia Program (SKPA)
Tackling TB and HIV Together in Papua New Guinea
TAIPAN: HIV cascade surveillance
Targeting HIV-infected macrophages to achieve an HIV cure
Targeting novel sites on reverse transcriptase for HIV treatment and prevention
The elimination of hepatitis C as a global public health threat
The impact of viral infections on immune ageing
The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
The persistence of HIV in monocytes and macrophages
The role of female genital tract microbial function in inflammation and HIV infection risk.
The role of monocytes in the development of cardiovascular disease
PATH Cohort Study
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2022 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
